National survey of patient symptoms and therapies among 707 women with a lipedema phenotype in the United States
Aaron W. Aday(Vanderbilt University Medical Center), Rachelle Crescenzi(University of Virginia Medical Center), Shannon L. Taylor(Vanderbilt University Medical Center), Karen L. Herbst(The Roxbury Institute), Manus J. Donahue(Vanderbilt University Medical Center), Sheau‐Chiann Chen(Vanderbilt University Medical Center), Niral Patel(Vanderbilt University Medical Center), Michael Pridmore(Vanderbilt University Medical Center), Vanessa Crain(Vanderbilt University Medical Center), John A Beasley(Vanderbilt University Medical Center), Joshua A. Beckman(Clinical Research Institute), Maria Garza(Vanderbilt University Medical Center), Paula M. C. Donahue(Vanderbilt University)
Cited by 34
Related Papers
COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up
|Journal of the American College of Cardiology|2020|2.9k
2011 ACCF/AHA Focused Update of the Guideline for the Management of Patients With Peripheral Artery Disease (Updating the 2005 Guideline)
|Journal of the American College of Cardiology|2011|928
Partial Thrombosis of the False Lumen in Patients with Acute Type B Aortic Dissection
|New England Journal of Medicine|2007|711
Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19.
|Bristol Research (University of Bristol)|2021|589
DC isoketal-modified proteins activate T cells and promote hypertension
|Journal of Clinical Investigation|2014|533